Market Overview:
The global antibody testing market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of infectious diseases, growing demand for rapid and accurate diagnosis, and technological advancements in antibody testing methods. The serological test kit segment is expected to dominate the global antibody testing market during the forecast period owing to its high accuracy and reliability. The immunoglobulin kits segment is projected to grow at a higher CAGR than other segments during the forecast period due to its increasing use in hospitals, academic and research institutes, diagnostic laboratories, biopharmaceutical companies, and homecare settings.
Product Definition:
An antibody is a protein molecule produced by the body's immune system in response to a foreign substance, such as a virus or bacteria. Antibodies are used by the immune system to identify and neutralize foreign substances.
Serological Test Kit:
A serological test is a medical procedure to detect the presence of antibodies in the blood. Antibodies are proteins made by the body in response to an antigen (body tissue or bacteria). Serological tests are used for detecting diseases and disorders such as rheumatoid arthritis, diabetes, multiple sclerosis, etc. These tests also determine whether a pregnant women is infected with HIV or not.
Immunoglobulin Kits:
Immunoglobulin (IG) kits are used for the detection of antibodies in human serum, plasma or whole blood. These tests are widely used by healthcare professionals to diagnose various diseases such as lupus, rheumatoid arthritis and other autoimmune disorders.
Application Insights:
The global market is segmented by application into hospital, academic and research institutes, diagnostic laboratories, biopharmaceutical companies and homecare settings. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to the rising prevalence of infectious diseases that require rapid testing for diagnosis at hospitals. Furthermore, increasing government funding for the development of advanced diagnostics tests at hospitals will further boost growth over the forecast period.
The academic and research institutes segment is expected to witness lucrative growth during the forecast period owing to an increase in government-sponsored initiatives for developing advanced diagnostics tests at prominent institutions across various countries worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a well-established healthcare infrastructure, high adoption rate of advanced diagnostic technologies, and increasing prevalence of infectious diseases. Moreover, rising number of product launches by major players is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare facilities and growing awareness regarding early diagnosis in emerging countries such as China and India. In addition, government initiatives for immunization programs are further expected to fuel market development during the forecast period.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the antibody testing market. Infectious diseases are caused by pathogenic microorganisms, which can spread from one person to another and cause serious health problems. The growing prevalence of infectious diseases has led to an increase in the demand for antibody testing products and services, thereby driving the growth of this market.
- Technological advancements: The development of new technologies has helped in the advancement of antibody testing products and services, thereby propelling the growth of this market. For instance, recent technological advancements have enabled laboratories to use next-generation sequencing (NGS) technology for accurate diagnosis and treatment decisions for patients with cancer or other complex disorders. This is expected to boost demand for antibody testing products and services in coming years.
- Roche Diagnostics announced that it will invest more than 0 million over five years in R&D initiatives aimed at developing innovative diagnostic solutions that will help improve patient care across key areas such as oncology, immunology ,and cardiovascular disease .Such investments are likelyto spur innovationinthismarketandhelp drive itsgrowthin future .
Scope Of The Report
Report Attributes
Report Details
Report Title
Antibody Testing Market Research Report
By Type
Serological Test Kit, Immunoglobulin Kits, Lateral Flow Assay Kits
By Application
Hospital, Academic and Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies, Homecare Settings
By Companies
Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Beckton, Dickinson and Company, F. Hoffmann-La Roche, Agilent Technologies, DiaSorin, Zeus Scientific, Abcam, Trinity Biotech, Werfen (Biokit), Promega, BioLegend, Meridian Bioscience, Bio-Techne (R&D Systems)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Antibody Testing Market Report Segments:
The global Antibody Testing market is segmented on the basis of:
Types
Serological Test Kit, Immunoglobulin Kits, Lateral Flow Assay Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Academic and Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies, Homecare Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Abbott Laboratories
- Bio-Rad Laboratories
- Beckton, Dickinson and Company
- F. Hoffmann-La Roche
- Agilent Technologies
- DiaSorin
- Zeus Scientific
- Abcam
- Trinity Biotech
- Werfen (Biokit)
- Promega
- BioLegend
- Meridian Bioscience
- Bio-Techne (R&D Systems)
Highlights of The Antibody Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Serological Test Kit
- Immunoglobulin Kits
- Lateral Flow Assay Kits
- By Application:
- Hospital
- Academic and Research Institutes
- Diagnostic Laboratories
- Biopharmaceutical Companies
- Homecare Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antibody Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antibody testing is a process used to determine if someone has an antibody against a particular antigen. Antibodies are proteins that the body produces in response to an infection or other foreign substance.
Some of the major players in the antibody testing market are Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Beckton, Dickinson and Company, F. Hoffmann-La Roche, Agilent Technologies, DiaSorin, Zeus Scientific, Abcam, Trinity Biotech, Werfen (Biokit), Promega, BioLegend, Meridian Bioscience, Bio-Techne (R&D Systems).
The antibody testing market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibody Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antibody Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antibody Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antibody Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antibody Testing Market Size & Forecast, 2018-2028
4.5.1 Antibody Testing Market Size and Y-o-Y Growth
4.5.2 Antibody Testing Market Absolute $ Opportunity
Chapter 5 Global Antibody Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antibody Testing Market Size Forecast by Type
5.2.1 Serological Test Kit
5.2.2 Immunoglobulin Kits
5.2.3 Lateral Flow Assay Kits
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antibody Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antibody Testing Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Academic and Research Institutes
6.2.3 Diagnostic Laboratories
6.2.4 Biopharmaceutical Companies
6.2.5 Homecare Settings
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antibody Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antibody Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antibody Testing Analysis and Forecast
9.1 Introduction
9.2 North America Antibody Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antibody Testing Market Size Forecast by Type
9.6.1 Serological Test Kit
9.6.2 Immunoglobulin Kits
9.6.3 Lateral Flow Assay Kits
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antibody Testing Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Academic and Research Institutes
9.10.3 Diagnostic Laboratories
9.10.4 Biopharmaceutical Companies
9.10.5 Homecare Settings
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antibody Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Antibody Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antibody Testing Market Size Forecast by Type
10.6.1 Serological Test Kit
10.6.2 Immunoglobulin Kits
10.6.3 Lateral Flow Assay Kits
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antibody Testing Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Academic and Research Institutes
10.10.3 Diagnostic Laboratories
10.10.4 Biopharmaceutical Companies
10.10.5 Homecare Settings
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antibody Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antibody Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antibody Testing Market Size Forecast by Type
11.6.1 Serological Test Kit
11.6.2 Immunoglobulin Kits
11.6.3 Lateral Flow Assay Kits
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antibody Testing Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Academic and Research Institutes
11.10.3 Diagnostic Laboratories
11.10.4 Biopharmaceutical Companies
11.10.5 Homecare Settings
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antibody Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Antibody Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antibody Testing Market Size Forecast by Type
12.6.1 Serological Test Kit
12.6.2 Immunoglobulin Kits
12.6.3 Lateral Flow Assay Kits
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antibody Testing Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Academic and Research Institutes
12.10.3 Diagnostic Laboratories
12.10.4 Biopharmaceutical Companies
12.10.5 Homecare Settings
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antibody Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antibody Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antibody Testing Market Size Forecast by Type
13.6.1 Serological Test Kit
13.6.2 Immunoglobulin Kits
13.6.3 Lateral Flow Assay Kits
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antibody Testing Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Academic and Research Institutes
13.10.3 Diagnostic Laboratories
13.10.4 Biopharmaceutical Companies
13.10.5 Homecare Settings
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antibody Testing Market: Competitive Dashboard
14.2 Global Antibody Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Abbott Laboratories
14.3.3 Bio-Rad Laboratories
14.3.4 Beckton, Dickinson and Company
14.3.5 F. Hoffmann-La Roche
14.3.6 Agilent Technologies
14.3.7 DiaSorin
14.3.8 Zeus Scientific
14.3.9 Abcam
14.3.10 Trinity Biotech
14.3.11 Werfen (Biokit)
14.3.12 Promega
14.3.13 BioLegend
14.3.14 Meridian Bioscience
14.3.15 Bio-Techne (R&D Systems)
